Yale Leader to Join OSU as New Dean of the College of Medicine

National leader, Dr. Charles J. Lockwood will become the next dean of The Ohio State University College of Medicine effective Sept. 1, subject to approval by the university’s Board of Trustees.

A national leader at the Yale University School of Medicine, Lockwood comes to Ohio State after nine years as the Anita O’Keeffe Young Professor and Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale.

“We have one of the great academic medical centers in the country, and Dr. Lockwood’s history of building strong relationships will create greater opportunities for team science and collaboration to further the academic and strategic goals of the University through our health sciences,” says The Ohio State University Executive Vice President and Provost Joseph A. Alutto.

Lockwood will also be vice president for health sciences, “Throughout his career, Charly has fostered a culture of collaboration, excellence and innovation, while keenly understanding the critical role that academic medical centers play in developing health care leaders and advancing the practice of medicine,” says Dr. Steven G. Gabbe, senior vice president for health sciences and CEO of The Ohio State University Medical Center. “By every measure, our College of Medicine is firmly established as one of the best inAmerica, and Charly’s talents will be instrumental in continuing that upward trajectory and leading us to even greater heights” said Gabbe.

“I deeply appreciate the diligence of the advisory committee, chaired by Dr. Robert Brueggemeier, dean of our College of Pharmacy. The committee had a challenging task of identifying and evaluating outstanding candidates,” he added.

Lockwood is editor-in-chief of Contemporary OB/GYN and section editor for obstetrics of “Up To Date,” an online resource for the medical community.

He received his undergraduate education at Brown University in developmental biology and graduated magna cum laude. He earned his medical degree from the University of Pennsylvania and completed his residency in obstetrics and gynecology at Pennsylvania Hospital. In addition to a fellowship in maternal-fetal medicine at the Yale-New Haven Hospital, he completed a postdoctoral fellowship in coagulation at the Mount Sinai Medical Center.

Prior to joining the Yale faculty he was chair of obstetrics and gynecology at New York University.  He also was director of perinatal research at Mount Sinai Medical Center in New York.

He is an elected member of the Institute of Medicine of the National Academies and Sigma Xi and Alpha Omega Alpha honor societies. A frequent invited speaker at professional meetings, Lockwood has more than 220 peer-reviewed publications and has edited four textbooks.

Lockwood is the past chair of the American College of Obstetricians and Gynecologists’ Committee on Obstetrical Practice and ACOG’s document review committee. He also has been secretary-treasurer and president of the Society for Gynecologic Investigation.

His research awards include multiple grants from the National Institutes of Health, March of Dimes and private foundations. His primary clinical interests include the prevention of recurrent pregnancy loss, preterm delivery, and maternal thrombophilias, and he has been credited with helping to develop fetal fibronectin, the first biochemical predictor of prematurity.


Comments are closed.